Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation

Human Reproduction

Volumn 17, Issue 1, 2002, Pages 213-218

  Ledee Bataille N ^a,c   Lapree Delage G ^a   Taupin, J L ^b   Dubanchet, S ^a   Frydman, R ^c   Chaouat, G ^a  

^a INSERM   (France)

^b CNRS   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Implantation; Leukaemia inhibitory factor; Tumour necrosis factor; Uterine flushing

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; LEUKEMIA INHIBITORY FACTOR; PROGESTERONE; PROVAMES; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BIOASSAY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; NIDATION; OUTCOMES RESEARCH; OVULATION INDUCTION; PREDICTION; PREGNANCY; RELIABILITY; TREATMENT FAILURE; UTERUS CAVITY; UTERUS FLUID;

EID: 0036158805     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.1.213     Document Type: Article

References (42)

1. Modulation of leukaemia inhibitory factor gene expression and protein biosynthesis in human endometrium
2. Effect of leukaemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway
3. Immuno-endocrine interactions in early pregnancy
4. Cytokines in implantation
5. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
6. Leukaemia inhibitory factor in human endometrium during the menstrual cycle: Cellular origin and action on production of glandular epithelial cell prostaglandin in vitro
7. Expression of leukaemia inhibitory factor and its receptor in preimplantation embryos
8. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation
9. FIVNAT. Influence of attempt rank in in-vitro fertilization
10. Hormonal control of endometrial receptivity. The egg donation model and controlled ovarian hyperstimulation
11. In-vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women
12. Implantation, interception and contraception
13. Immunologically mediated abortion (IMA). A minireview
14. Leukaemia inhibitory factor gene mutations in infertile women
15. Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine
16. Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs
17. Tumor necrosis factor and underlying infection
18. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins
19. Expression and regulation of the tumour necrosis factor-alpha gene in the female reproductive tract
20. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium
21. The production of leukaemia inhibitory factor by human endometrium: Presence in uterine flushings and production by cells in culture
22. Integrins in the endometrium of women with endometriosis
23. Concentration of endometrial protein PP14 in uterine flushings throughout the menstrual cycle in normal, fertile women
24. Evaluation of an optimal luteal support protocol in IVF
25. Placental protein 14 levels in uterine flushing and plasma of women with unexplained infertility
26. The effect of leukemia inhibitory factor (LIF) on trophoblast differentiation: A potential role in human implantation
27. Dating the endometrial biopsy
28. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle
29. Immunological evidence for a human ovarian tumor necrosis factor-alpha
30. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos
31. Cytokines and embryo implantation
32. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor
33. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium
34. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window
35. A monoclonal antibody based elisa for quantitation of human leukaemia inhibitory factor
36. Review: The role of leukaemia inhibitory factor in the establishment of pregnancy
37. Leukaemia inhibitory factor in human endometrium throughout the menstrual cycle
38. Tumour necrosis factor-alpha (TNF-alpha) in human endometrium and uterine secretion: An evaluation by immunohistochemistry, ELISA and semiquantitative RT-PCR
39. Molecular cloning of the complementary DNA for human tumor necrosis factor
40. Leukemia inhibitory factor, leukemia inhibitory factor receptor, and glycoprotein 130 in rhesus monkey uterus during menstrual cycle and early pregnancy
41. Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: An in-vitro system
42. Cytokine involvement in oocytes and early embryos